Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

17 results
Display

Journal of Stroke (JoS) Receives High Impact Factor

Kim JS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Overall and Gender-specific Associations between C-reactive Protein and Stroke Occurrence: A Cross-sectional Study in US

Peng Y, Dong B, Wang Z

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms

Kim JS

Post-stroke mood and emotional disturbances are frequent and diverse in their manifestations. Out of the many post-stroke disturbances, post-stroke depression, post-stroke anxiety, post-stroke emotional incontinence, post-stroke anger proneness, and post-stroke...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Neural Stem Cells and Ischemic Brain

Zhang Z, Chopp M

Stroke activates neural stem cells in the ventricular-subventricular zone (V/SVZ) of the lateral ventricle, which increases neuroblasts and oligodendrocyte progenitor cells (OPCs). Within the ischemic brain, neural stem cells, neuroblasts...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imaging Predictors for Atherosclerosis-Related Intracranial Large Artery Occlusions in Acute Anterior Circulation Stroke

Suh HI, Hong JM, Lee KS, Han M, Choi JW, Kim JS, Demchuk AM, Lee JS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Traditional Risk Factors for Stroke in East Asia

Kim YD, Jung YH, Saposnik G

Stroke is one of the leading causes of death and morbidity worldwide. The occurrence of stroke is strongly dependent on well-known vascular risk factors. After rapid modernization, urbanization, and mechanization,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adult Stem Cell Therapy for Stroke: Challenges and Progress

Bang OY, Kim EH, Cha JM, Moon GJ

Stroke is one of the leading causes of death and physical disability among adults. It has been 15 years since clinical trials of stem cell therapy in patients with stroke...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Herbs and Rehabilitation after Stroke Study: A Multi-center, Double-blinded, Randomized Trial in Hong Kong

Cheung R, Xiong L, Chang SK, Tse CT, Pang YY, Mok V, Leung T, Tsoi TH, Li R, Mok M, Chang CM, Lau KK, Sheng B, Li T, Yeung J, Leung PC, Chook P, Wong KS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Difference in the Location and Risk Factors of Cerebral Microbleeds According to Ischemic Stroke Subtypes

Kim BJ, Yoon Y, Sohn H, Kang DW, Kim JS, Kwon SU

BACKGROUND AND PURPOSE: The location of cerebral microbleeds (CMBs) may differ according to ischemic stroke subtype, and the underlying pathomechanism may differ by their location. Here, we investigated the characteristics...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multiple Embolic Infarction Due to a Primary Aortic Intimal Sarcoma

Mo H, Kwon HM, Choi JS, Ahn SJ, Lee YS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Direct Thrombus Imaging in Stroke

Kim J, Park JE, Nahrendorf M, Kim DE

There is an emergent need for imaging methods to better triage patients with acute stroke for tissue-plasminogen activator (tPA)-mediated thrombolysis or endovascular clot retrieval by directly visualizing the size and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence and Characteristics of Unruptured Cerebral Aneurysms in Ischemic Stroke Patients

Kim JH, Suh SH, Chung J, Oh YJ, Ahn SJ, Lee KY

BACKGROUND AND PURPOSE: The prevalence of unruptured cerebral aneurysms (UCAs) in ischemic stroke patients is not clearly defined. This study aimed to measure the prevalence and characteristics of UCAs in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association of Left Atrial Enlargement with Cortical Infarction in Subjects with Patent Foramen Ovale

Lee MJ, Park SJ, Yoon CH, Hwang JW, Ryoo S, Kim SJ, Kim GM, Chung CS, Lee KH, Bang OY

BACKGROUND AND PURPOSE: Left atrial dysfunction has been reported in patients with patent foramen ovale (PFO). Here we investigated the role of left atrial dysfunction in the development of embolic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association between Aortic Atheroma and Cerebral Small Vessel Disease in Patients with Ischemic Stroke

Song TJ, Kim YD, Yoo J, Kim J, Chang HJ, Hong GR, Shim CY, Song D, Heo JH, Nam HS

BACKGROUND AND PURPOSE: Cerebral small vessel disease (SVDs) are related with large artery atherosclerosis. However, the association between aortic atheroma (AA) and cerebral small vessel disease has rarely been reported....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reduction of Midline Shift Following Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction

Jeon SB, Kwon SU, Park JC, Lee DH, Yun SC, Kim YJ, Ahn JS, Kwun BD, Kang DW, Choi HA, Lee K, Kim JS

BACKGROUND AND PURPOSE: Hemicraniectomy is a decompressive surgery used to remove a large bone flap to allow edematous brain tissue to bulge extracranially. However, early indicators of the decompressive effects...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Extended Use of Hypothermia in Elderly Patients with Malignant Cerebral Edema as an Alternative to Hemicraniectomy

Jeong HY, Chang JY, Yum KS, Hong JH, Jeong JH, Yeo MJ, Bae HJ, Han MK, Lee K

BACKGROUND AND PURPOSE: The use of decompressive hemicraniectomy (DHC) for the treatment of malignant cerebral edema can decrease mortality rates. However, this benefit is not sufficient to justify its use...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prestroke Antiplatelet Effect on Symptomatic Intracranial Hemorrhage and Functional Outcome in Intravenous Thrombolysis

Choi JC, Lee JS, Park TH, Cho YJ, Park JM, Kang K, Lee KB, Lee SJ, Kim JG, Lee J, Park MS, Choi KH, Kim JT, Yu KH, Lee BC, Oh MS, Cha JK, Kim DH, Nah HW, Kim DE, Ryu WS, Kim BJ, Bae HJ, Kim WJ, Shin DI, Yeo MJ, Sohn SI, Hong JH, Lee J, Hong KS

BACKGROUND AND PURPOSE: About 30%-40% of stroke patients are taking antiplatelet at the time of their strokes, which might increase the risk of symptomatic intracranial hemorrhage (SICH) with intravenous tissue...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr